Legora · 20 hours ago
Director of Tax
Legora is redefining how legal work gets done with its AI-native workspace designed for legal professionals. The Director of Tax will be responsible for leading all tax matters globally, ensuring compliance, and providing strategic tax guidance to the leadership team.
Artificial Intelligence (AI)LegalLegal TechSoftware
Responsibilities
Own and lead all tax matters across provision, compliance, planning, and strategy on a global basis
Serve as the primary point of accountability for tax across the company
Operate as a trusted partner to Finance, Legal, and the executive team
Lead GAAP tax provision, tax reserves, and related disclosures
Ensure compliance across U.S. federal, state, and international tax requirements
Assess the tax impact of strategic, product, and commercial initiatives and provide clear, decision-ready guidance to leadership
Build scalable processes and infrastructure that reduce manual work and enable real-time insight into global tax scenarios
Partner closely with Legal (including the U.S. and Ireland) on tax, structuring, and commercial matters
Work cross-functionally with Accounting, Treasury, HR, and other key stakeholders
Build, lead, and mentor a high-performing tax team as Legora grows
Qualification
Required
10+ years of experience in tax, including significant experience owning or leading a global tax function
Strong background in tax accounting, including valuation allowances, stock-based compensation, and international tax structures
Proven ability to translate business strategy into clear tax implications and recommendations
Comfortable operating at both strategic and executional levels in a fast-moving environment
Company
Legora
Legora is a collaborative AI that empowers lawyers by enabling them to review documents, conduct research, and draft legal materials.
Funding
Current Stage
Growth StageTotal Funding
$266MKey Investors
Bessemer Venture PartnersRedpointBenchmark
2025-10-30Series C· $150M
2025-05-21Series B· $80M
2024-07-17Series A· $25M
Recent News
2026-01-22
2025-12-25
Company data provided by crunchbase